Zura Bio Inc

This study tests a new drug called tibulizumab for adults with systemic sclerosis, a rare disease that causes skin thickening and can affect internal organs. About 80 participants will receive either the drug or a placebo for 24 weeks, followed by an open-label period where every…

This study tests a new drug called tibulizumab for adults with hidradenitis suppurativa (HS), a chronic skin condition causing painful lumps. About 225 people will receive either the drug or a placebo for 16 weeks, then all can get the drug for another 16 weeks. The goal is to se…